Nationwide Children’s Hospital in Columbus and Transformatix Technologies of Davis, California, have partnered to create BioLinQ, a new biomedical informatics company designed to supply advanced software solutions for disease diagnosis, medical research, and clinical trials.

“Years of development at Nationwide Children’s Hospital funded in part by the National Institutes of Health have laid the foundation for very mature, high-end solutions in digital pathology, biospecimen analysis and biorepository management,” said Transformatix Technologies Founder and CEO Ken Murray. “With the growth of molecular technology and the advent of personalized medicine, BioLinQ is poised to have a significant impact upon the diagnostic and research capabilities in hospitals, academic research centers and the pharmaceutical industry.”

BioLinQ will be based in Dublin, a northwest suburb of Columbus. The BioLinQ suite of web-based solutions encompasses pathology biospecimen analysis, workflow management, long-distance collaboration, and efficient management of laboratory and biorepository functions.

“We are seeing, with the implementation of our software, the optimization of the scientific review process for translational research. The solutions also provide visualization into the multiple dynamics of clinical trial data to aid in clinical study design,” explained Dave Billiter, director, Informatics, The Research Institute at Nationwide Children’s Hospital. “For example, we have a cancer consortium which called for patients to receive rapid review in order to qualify for a specific trial. Because we had this powerful suite of software, we were able to quickly accommodate the consortium and more importantly enroll the patients in the study.”

photo credit: Ottawa-Carleton Institute of Biology